Amelioratebiotech


Biotech company focused on development of early‑stage diagnostic technologies, biosimilars and nutraceuticals. States a mission to develop novel platform technologies, manufacture biopharma products and health supplements, and to provide affordable, quality products with an emphasis on research, technology and partnerships.

Industries

Biotechnology
Business Development
Product Research
Biotechnology Research

Nr. of Employees

small (1-50)


Products

Early-stage diagnostics products

Products aimed at early detection and addressing unmet diagnostic needs (no product-level details published on site).

Biosimilar therapeutics

Development and production of biosimilar therapeutic products (site references biosimilars without product specifics).

Nutraceuticals and health supplements

Formulation and production of nutraceutical and health supplement products.

Amprogen-In

Novel formulation of probiotics to improve gastro-intestinal conditions, marketed for malnutrition problems.


Services

Manufacturing and market-facing activities for biopharmaceuticals and health supplements.

R&D services for diagnostic products and underlying platform technologies, including prototyping.

Expertise Areas

  • Early-stage diagnostics
  • Biosimilar development
  • Nutraceutical development
  • Platform technology R&D
  • Show More (4)

Key Technologies

  • Diagnostic assay development
  • Platform technology development
  • Bioprocess development and scale-up
  • Product formulation for supplements
  • Show More (1)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.